Skip to main content

Access to Prescription Digital Therapeutics Act

By Jessica Hagen | 01:37 pm | September 22, 2023
Jennifer Mathieu, senior vice president of professional and government affairs at AMCP, provides an update on the Access to Prescription Digital Therapeutics Act 2023 moving through Congress.
By Jessica Hagen | 12:12 pm | December 20, 2022
Some experts assert the legislation is preemptive and may stifle innovation, while others argue it has the potential to improve patient access to meaningful healthcare.